Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells-Reference-Cited by-同舟云学术

Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells

Published:2004-03 Issue:13 Volume:279 Page:12868-12875
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Romsicki Yolanda,Reece Mark,Gauthier Jacques-Yves,Asante-Appiah Ernest,Kennedy Brian P.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference30 articles.

1. Insulin signalling and the regulation of glucose and lipid metabolism

2. Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function.

3. Identification of the cysteine residues involved in the class I disulfide bonds of the human insulin receptor: properties of insulin receptor monomers.

4. Folding of Insulin Receptor Monomers Is Facilitated by the Molecular Chaperones Calnexin and Calreticulin and Impaired by Rapid Dimerization

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico De Novo Discovery of Novel Target-specific Drug-like Bidentate Inhibitors of PTP 1B;Letters in Drug Design & Discovery;2024-03

2. BACH1 controls hepatic insulin signaling and glucose homeostasis in mice;Nature Communications;2023-12-21

3. Tomato sucrose transporter SlSUT4 participates in flowering regulation by modulating gibberellin biosynthesis;Plant Physiology;2023-03-21

4. The PTP1B inhibitor MSI-1436 ameliorates liver insulin sensitivity by modulating autophagy, ER stress and systemic inflammation in Equine metabolic syndrome affected horses;Frontiers in Endocrinology;2023-03-20

5. Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity;Current Pharmaceutical Design;2022-05